← Return to Clinical Trials Feed
📅 TRIAL CALENDAR

Clinical Trials Calendar 2026

50 clinical trials with confirmed start dates — sorted by most recent. Track recruiting studies across all phases, conditions, and sponsors worldwide.

TRIALS: 50 // RECRUITING: 50 // SOURCE: CLINICALTRIALS.GOV // UPDATED: DAILY

A 2026 start date is a plan, not a fact

Every study on ClinicalTrials.gov has a start date, and each one is labelled either actual (it happened) or estimated (it's what the sponsor hopes). Most people never notice the label. It matters more than it looks.

On 28 September 2026 we counted every registered study, in any status, with a start date somewhere in 2026. Here's how those dates are holding up:

Planned start Studies Confirmed started Still an estimate Still "not yet recruiting" Withdrawn
January 2026 3,902 2,437 1,465 1,228 72
February 2026 3,153 2,009 1,144 971 27
March 2026 3,545 2,223 1,322 1,130 35
April 2026 3,577 1,934 1,643 1,385 34
May 2026 3,216 1,692 1,524 1,294 35
June 2026 3,586 1,594 1,992 1,690 56
July 2026 3,109 1,248 1,861 1,590 31
August 2026 3,065 890 2,175 1,830 24
September 2026 4,007 391 3,616 3,122 30
October 2026 1,938 0 1,938 1,769 14
November 2026 588 0 588 542 9
December 2026 580 0 580 508 17

Look at January. 3,902 studies said they would start that month. Nine months later, 1,228 of them are still marked "not yet recruiting", and 1,465 still carry an estimated date rather than an actual one. That's more than a third of the month's studies with nothing confirmed. February, March and April look much the same.

The registry doesn't say why. Part of the gap can be a record that simply hasn't been updated yet, and part can be a study that really hasn't opened. From the outside you can't tell which, and that's exactly the problem if you're waiting on one. What the data does show is that only 72 of the January studies have been formally withdrawn. The rest are still listed, still undated, still "coming."

The further out you look, the softer the numbers get. Every October, November and December date is an estimate by definition, and 3,616 of September's 4,007 studies hadn't confirmed a start as the month was ending.

Checking a start date yourself takes a minute

  1. Open the study on ClinicalTrials.gov and find Study Start. If it says (Estimated) and the date is already in the past, treat it as unconfirmed.
  2. Check Last Update Posted. A record nobody has touched for a year tells you more about the study than the start date does.
  3. Scroll to the locations list. A site marked Recruiting is the only real signal that someone near you can actually enrol. The overall status can be ahead of or behind what individual sites are doing.

Counts from the ClinicalTrials.gov API v2, all statuses, 28 September 2026. The calendar below is different: it only shows studies from ClinicalMetric's own recruiting feed, grouped by the start date on their record.

November 2026 (1 trials)

NCT07672483 Phase 1
Recruiting
IL-12 Genetically Engineered Myeloid Cells in Participants With Relapsed, Refrac...
Condition
Relapsed Solid Tumor Malignancies
Start Date
Nov 4, 2026
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →

May 2026 (2 trials)

NCT07619846 N/A
Recruiting
Using Chin Bone Rings for Sinus Lifting and Dental Implants in One Surgery
Condition
Maxillary Deficiency
Start Date
May 31, 2026
Location
Syria
Sponsor
Damascus University
View Trial →
NCT07562997 N/A
Recruiting
Sodium and Milk Fortification Evaluation of Body Composition Among Very Preterm ...
Condition
Very Preterm and Extremely Preterm Birth
Start Date
May 18, 2026
Location
United States
Sponsor
University of Washington
View Trial →

April 2026 (2 trials)

NCT07522879 Phase 2
Recruiting
A Study of Becotatug Vedotin (MRG003) Combined With Epirubicin as Neoadjuvant Th...
Condition
Adenoid Cystic Carcinoma
Start Date
Apr 28, 2026
Location
China
Sponsor
Eye & ENT Hospital of Fudan Un
View Trial →
NCT07432113 N/A
Recruiting
Prediction of Infectious Agents in the Biofire® FilmArray bioMérieux Meningitis/...
Condition
Meningitis
Start Date
Apr 13, 2026
Location
Brazil
Sponsor
Federal University of Health S
View Trial →

February 2026 (3 trials)

NCT07428291 N/A
Recruiting
Early Rehabilitationin in Tibial Spine Avulsion Fracture Managed With Arthoscopi...
Condition
Avulsion Fracture
Start Date
Feb 27, 2026
Location
Pakistan
Sponsor
Abdul Jabbar
View Trial →
NCT05652361 N/A
Recruiting
Machine Learning-based Surgical Guidance System for Robot-assisted Rectal Surger...
Condition
Rectum Cancer
Start Date
Feb 25, 2026
Location
Germany
Sponsor
Technische Universität Dresden
View Trial →
NCT07858760 N/A
Recruiting
Study of the Care Pathway of Patients Admitted to the Palliative Care Unit of St...
Condition
Advanced Chronic Disease
Start Date
Feb 22, 2026
Location
France
Sponsor
University Hospital, Strasbour
View Trial →

January 2026 (2 trials)

NCT07643896 N/A
Recruiting
The ADVANCE (Assay Development and Validation for Pre-Natal and Obstetric Condit...
Condition
Pregnant Individuals
Start Date
Jan 10, 2026
Location
United States
Sponsor
BillionToOne Inc.
View Trial →
NCT07318818 Phase 1, Phase 2
Recruiting
A Clinical Trial of P134 Cells in Recurrent Glioblastoma
Condition
Recurrent Glioblastoma IDH Wildtype
Start Date
Jan 5, 2026
Location
China
Sponsor
Tasly Pharmaceutical Group Co.
View Trial →

December 2025 (1 trials)

NCT07481396 N/A
Recruiting
Molecular Insights Into Post-Cardiac Arrest Brain Injury Via CSF Multi-Omics
Condition
Cardiac Arrest (CA)
Start Date
Dec 1, 2025
Location
South Korea
Sponsor
Chungnam National University H
View Trial →

October 2025 (3 trials)

NCT07208591 Phase 3
Recruiting
To Evaluate The Safety and Efficacy of STSA-1002 Injection in Patients With Acut...
Condition
Acute Respiratory Distress Syndrome (ARDS)
Start Date
Oct 31, 2025
Location
China
Sponsor
Staidson (Beijing) Biopharmace
View Trial →
NCT07229417 Phase 2
Recruiting
A Trial Evaluating the Efficacy of Ivonescimab in Metastatic Endocrine Refractor...
Condition
Metastatic Endocrine Refractory
Start Date
Oct 22, 2025
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT07235982 N/A
Recruiting
Shoulder Anterior Capsular Block and Intraarticular Steroid Injection Versus Int...
Condition
Analgesia
Start Date
Oct 1, 2025
Location
Egypt
Sponsor
Zagazig University
View Trial →

September 2025 (3 trials)

NCT07190196 Phase 3
Recruiting
A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adul...
Condition
Immunoglobulin G4 Related Disease
Start Date
Sep 26, 2025
Location
United States, Argentina, Belgium
Sponsor
Sanofi
View Trial →
NCT06788262 N/A
Recruiting
Cerebral and Cognitive Impact of Female Professional SoccerPractice
Condition
Traumatic Chronic Encephalopathy
Start Date
Sep 13, 2025
Location
France
Sponsor
University Hospital, Strasbour
View Trial →
NCT07413718 N/A
Recruiting
Inspiratory Muscle Training in Amiotrophyc Lateral Sclerosis
Condition
Amyotrophic Lateral Slerosis
Start Date
Sep 1, 2025
Location
Spain
Sponsor
University Ramon Llull
View Trial →

August 2025 (1 trials)

NCT07265297 Phase 3
Recruiting
Using Hydroxychloroquine (HCQ) to Treat Steatohepatitis
Condition
Steatohepatitis, Nonalcoholic
Start Date
Aug 12, 2025
Location
Taiwan
Sponsor
National Taiwan University Hos
View Trial →

July 2025 (1 trials)

NCT07215689 N/A
Recruiting
Effects of KSM-66 Ashwagandha® (300 mg) on Skin and Hair Health in Healthy Men a...
Condition
Skin Health
Start Date
Jul 11, 2025
Location
United States
Sponsor
SF Research Institute, Inc.
View Trial →

June 2025 (2 trials)

NCT07483827 Phase 1
Recruiting
A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CP...
Condition
C3 Glomerulopathy (C3G)
Start Date
Jun 26, 2025
Location
Austria, Belgium, Czechia
Sponsor
eleva GmbH
View Trial →
NCT07358182 N/A
Recruiting
Efficacy and Safety of Trastuzumab-rezetecan in HER2-Expressing Breast Cancer
Condition
Trastuzumab-rezetecan
Start Date
Jun 1, 2025
Location
China
Sponsor
Sun Yat-Sen Memorial Hospital
View Trial →

May 2025 (1 trials)

NCT07457762 N/A
Recruiting
AIRDROP: Can we Improve Adherence to Inhaled Treatment for Pulmonary Arterial Hy...
Condition
Pulmonary Arterial Hypertension (PAH)
Start Date
May 1, 2025
Location
Brazil
Sponsor
University of Sao Paulo Genera
View Trial →

March 2025 (2 trials)

NCT06119789 Phase 2
Recruiting
Precision Cancer Therapy in Rare Cancers
Condition
Rare Malignant Neoplasm
Start Date
Mar 20, 2025
Location
Norway
Sponsor
Oslo University Hospital
View Trial →
NCT07056920 N/A
Recruiting
Evaluation of Horizontal Bone Gain of Ridge Augmentation Using Customized Porous...
Condition
Horizontal Ridge Deficiency
Start Date
Mar 15, 2025
Location
Egypt
Sponsor
Ahmed Shawky
View Trial →

February 2025 (1 trials)

NCT06184503 N/A
Recruiting
Analysis of Velmanase Alfa (Lamzede®)'s Effects in the Body of Children With Alp...
Condition
Alpha-Mannosidosis
Start Date
Feb 19, 2025
Location
United States
Sponsor
Chiesi Farmaceutici S.p.A.
View Trial →

December 2024 (2 trials)

NCT06552091 N/A
Recruiting
Guided Digital Self-Hypnosis Solution for Managing Hot Flashes in Patients Under...
Condition
Breast Cancer Female
Start Date
Dec 20, 2024
Location
France
Sponsor
Institut de Cancérologie de Lo
View Trial →
NCT06547788 N/A
Recruiting
LEFT ATRIAL MONITORING IN PATIENTS BEFORE AND AFTER MITRAL SURGERY - LAMBDA STUD...
Condition
Mitral Regurgitation
Start Date
Dec 19, 2024
Location
Canada
Sponsor
Ottawa Heart Institute Researc
View Trial →

November 2024 (2 trials)

NCT06330090 N/A
Recruiting
COgnitive Dynamics in Early Childhood
Condition
Cognitive Change
Start Date
Nov 18, 2024
Location
Netherlands
Sponsor
Radboud University Medical Cen
View Trial →
NCT06698679 N/A
Recruiting
The Association Between Plasma Metabolites and the Risk, Efficacy and Prognosis ...
Condition
Breast Cancer
Start Date
Nov 15, 2024
Location
China
Sponsor
Shengjing Hospital
View Trial →

June 2024 (2 trials)

NCT06174103 N/A
Recruiting
BiVACOR® Total Artificial Heart Early Feasibility Study
Condition
Heart Failure
Start Date
Jun 26, 2024
Location
United States
Sponsor
BiVACOR Inc.
View Trial →
NCT06443346 N/A
Recruiting
Prospective Registry of EoSinophilic esOphagitis
Condition
Eosinophilic Esophagitis
Start Date
Jun 1, 2024
Location
Italy
Sponsor
IRCCS San Raffaele
View Trial →

March 2024 (2 trials)

NCT06184880 N/A
Recruiting
Effect of Physical Activity Program on Sedentary of Patients With Upper Aerodige...
Condition
Upper Aerodigestive Tract Cancer
Start Date
Mar 19, 2024
Location
France
Sponsor
Centre Hospitalier de Valence
View Trial →
NCT06249880 N/A
Recruiting
Pediatric Normative Markerless Movement Analysis
Condition
Pediatric ALL
Start Date
Mar 1, 2024
Location
United States
Sponsor
MultiCare Health System Resear
View Trial →

February 2024 (2 trials)

NCT06241846 Phase 2
Recruiting
A Phase II Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201...
Condition
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Start Date
Feb 22, 2024
Location
China
Sponsor
MediLink Therapeutics (Suzhou)
View Trial →
NCT05389410 N/A
Recruiting
PICO 7 vs PICO 14 in Revision Hip and Revision Knee Surgery.
Condition
Surgical Wound
Start Date
Feb 14, 2024
Location
United Kingdom
Sponsor
Robert Jones and Agnes Hunt Or
View Trial →

January 2024 (1 trials)

NCT06361420 N/A
Recruiting
Driving Pressure-guided Lung Protective Ventilation
Condition
Hypoxemia
Start Date
Jan 26, 2024
Location
China
Sponsor
Yong Lin, PhD
View Trial →

November 2023 (2 trials)

NCT05658640 Phase 1, Phase 2
Recruiting
HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapse...
Condition
Acute Lymphoblastic Leukemia, in Relapse
Start Date
Nov 14, 2023
Location
Austria, Belgium, Denmark
Sponsor
Princess Maxima Center for Ped
View Trial →
NCT06019468 Phase 2
Recruiting
Neoadjuvant Treatment For Locally Advanced Thymic Cancer
Condition
Thymic Carcinoma
Start Date
Nov 4, 2023
Location
China
Sponsor
Shanghai Pulmonary Hospital, S
View Trial →

July 2023 (1 trials)

NCT05932680 Phase 2
Recruiting
Limited-duration Teclistamab
Condition
Myeloma Multiple
Start Date
Jul 5, 2023
Location
United States
Sponsor
Abramson Cancer Center at Penn
View Trial →

June 2023 (1 trials)

NCT05378841 N/A
Recruiting
Efficacy of Surgical Joint Denervation in Painful Digital Osteoarthritis
Condition
Osteoarthritis Hand
Start Date
Jun 5, 2023
Location
France
Sponsor
Assistance Publique - Hôpitaux
View Trial →

February 2023 (2 trials)

NCT05766059 N/A
Recruiting
Novel Non-invasive Brain Stimulation Techniques in Neurological Rehabilitation
Condition
Stroke
Start Date
Feb 8, 2023
Location
Italy
Sponsor
Istituto Auxologico Italiano
View Trial →
NCT07014410 Phase 2
Recruiting
Pyrotinib Combined With Dalpiciclib Combined With Letrozole in ER-positive and H...
Condition
Breast Cancer
Start Date
Feb 1, 2023
Location
China
Sponsor
Zhejiang Cancer Hospital
View Trial →

January 2023 (1 trials)

NCT05777824 Phase 2
Recruiting
Postoperative Management for HNSCC Based on Pathological Response of Induction C...
Condition
Head and Neck Cancer
Start Date
Jan 1, 2023
Location
China
Sponsor
Cancer Institute and Hospital,
View Trial →

November 2022 (1 trials)

NCT05407480 N/A
Recruiting
Thereapeutic Recommendantion for Children With a Hodgkin Lymphoma
Condition
Staging
Start Date
Nov 15, 2022
Location
France
Sponsor
French Africa Pediatric Oncolo
View Trial →

September 2022 (1 trials)

NCT05514327 N/A
Recruiting
A Study of Ultra-fraction Radiotherapy Bridging CART in R/R DLBCL
Condition
Diffuse Large B Cell Lymphoma
Start Date
Sep 1, 2022
Location
China
Sponsor
Peking Union Medical College H
View Trial →

May 2022 (1 trials)

NCT06788873 N/A
Recruiting
Comparison of Cervical Cerclage by Vaginal and by Laparoscopic Transabdominal Ro...
Condition
Cerclage, Cervical
Start Date
May 15, 2022
Location
Italy
Sponsor
IRCCS Azienda Ospedaliero-Univ
View Trial →

April 2022 (2 trials)

NCT06777017 N/A
Recruiting
Can Hepatic-splenic Elastography Predict the Risk of Hepatocellular Recurrence A...
Condition
HCC - Hepatocellular Carcinoma
Start Date
Apr 22, 2022
Location
Italy
Sponsor
IRCCS Azienda Ospedaliero-Univ
View Trial →
NCT05358574 N/A
Recruiting
PMCF Study on the Safety, Performance and Clinical Benefits Data of the Anatomic...
Condition
Revision of a Shoulder Prosthesis
Start Date
Apr 22, 2022
Location
Germany
Sponsor
Zimmer Biomet
View Trial →

March 2022 (1 trials)

NCT05489068 N/A
Recruiting
Motivational Interviewing at Intake vs Intake as Usual on Client Engagement in A...
Condition
Substance-Related Disorders
Start Date
Mar 16, 2022
Location
United States
Sponsor
University of New Mexico
View Trial →

June 2016 (1 trials)

NCT02811510 Phase 1
Recruiting
Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol ...
Condition
Cannabis
Start Date
Jun 1, 2016
Location
United States
Sponsor
Yale University
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology